CQDM sets up a collaboration between Simon Fraser University, Amgen, Merck, Servier and GlycoNet to develop new chemistry to facilitate drug development and manufacturing MONTREAL, June 2nd, 2021 – CQDM is proud to announce a partnership with 3 major pharmaceutical companies, Amgen Canada, Merck Canada, Servier Canada and the Canadian Glycomics Network (GlycoNet) as part…
Montréal, May 11, 2021 – The Institute for Data Valorization (IVADO) is pleased to announce the signing of network partnerships with the Consortium de recherche biopharmaceutique (CQDM, biopharmaceutical research consortium), the Industrial Consortium for Research and Innovation in Medical Technologies (MEDTEQ+) and Montréal InVivo, the life sciences and health technologies (LSHT) cluster of Greater Montréal.…
MONTREAL, April 28, 2021 — The chairman of the Board of Directors of CQDM, Richard Fajzel, and Diane Gosselin, President and CEO, are very pleased to announce the appointment of Brian Underdown as the new chairman on its Scientific Advisory Board (SAB). Also, David Bouffard, Christine Brideau and Benjamin Haibe-Kains are joining this strategic committee,…
Montréal – Québec – March 15, 2021 – 48Hour Discovery(48HD) and CQDM are proud to announced that the company has been awarded $800,000 for peptide drug discovery using its patented drug discovery platform. The two-year project is funded through the CQDM Quantum Leap program, which supports exploration of innovative technologies, tools, and platforms that accelerate…
Pr. David Y. Thomas / Pr. John Hanrahan Montreal (Quebec), February 25, 2021—CQDM is proud to announce the launch of a $2,025,077 international collaborative project to support the preclinical stages of new drug candidates to treat an orphan lung disease. Led by Professor David Y. Thomas of McGill University, this multi-partner project focuses on the development…
On January 20th, CQDM’s President and CEO, Diane Gosselin, participated in the pre-budget consultations held by the team of Finance Minister Eric Girard. This exercise allowed us to share our thoughts and submit our proposals for the next Quebec government budget. To view the brief: click here. In the wake of the pandemic, we have…
Only in French: Lettre ouverte – Rédigée par Mme Marie-Pierre Ippersiel, présidente et directrice générale, PRIMA Québec, et co-signée par les Directeurs généraux des RSRI * In its November 30 economic update, the Government of Canada announced $250 million over five years, starting next year, to support companies in innovation to stimulate growth and job…
Montréal (Quebec), November 19, 2020 — The prize rewards VLPExpressTM, a plant-based vaccine discovery platform developed by Medicago in collaboration with McGill and Laval universities. The project was funded in 2009 by CQDM with contributions from Pfizer, Merck, the Ministère de l’Économie et de l’Innovation, and the Business-Led Networks of Centres of Excellence program from…
Montreal – November 11 2020 – CQDM congratulates Mesentech on securing additional investment to support the clinical development of their bone-targeting drug candidate MES-1007, a drug with the potential to reverse bone wastage in Duchenne Muscular Dystrophy and other skeletal fragility diseases in pediatrics. Link to Mesentech’s Press Release: click here. “CQDM’s investment enabled Mesentech…
Dr. Christian Dansereau – Dr. Jean-Claude Tardif – Dr. Fouzia Laghrissi-Thode A collaboration between Perceiv AI, DalCor Pharmaceuticals and the Montreal Heart Institute Montreal (Quebec), November 5, 2020 — The CQDM is pleased to announce the launch of a $600,000 collaborative project in biopharma and artificial intelligence (AI) to develop an AI-driven precision medicine tool.…